Â鶹´«Ã½

Philip McCarthy, MD

Philip McCarthy, MD

Roswell Park Comprehensive Cancer Center

Director of the Blood and Marrow Transplant Center

Expertise: Blood CancerBlood CancerBone MarrowBone MarrowBone Marrow TransplantBone Marrow TransplantCancerCancerhematologic oncologyhematologic oncologyLeukemiaLeukemiaLymphomaLymphomaMultiple MyelomaMultiple Myeloma

Director of the Blood and Marrow Transplant Center, Roswell Park Cancer Institute
Areas of expertise: Bone marrow transplant, leukemia, lymphoma, multiple myeloma, blood cancer, hematologic oncology

No Clipping

No Research/Citations

Roswell Park Study: Delaying Antiviral Treatment May Boost Immunity in Stem Cell Transplant Recipients

Patients who develop cytomegalovirus infections after allogeneic stem cell transplantation may be able to develop an immunity against the virus, strengthen their immune system and reduce reliance on strong antiviral medications, a team from Roswell Park reports in the journal Biology of Blood and Marrow Transplantation.
25-Aug-2020 12:50:26 PM EDT

Roswell Park Suggests New Strategy for Controlling Graft vs. Host Disease in Blood/Marrow Transplant Recipients

New preclinical work by a team of researchers from Roswell Park Comprehensive Cancer Center’s Transplant and Cellular Therapy Program suggests that the risk of developing acute graft vs. host disease (GVHD) during allogeneic blood/marrow transplant (BMT) — a potentially curative treatment for selected patients with hematologic disorders — can be decreased using an existing class of drugs called beta adrenergic agonists.
12-Jun-2020 12:30:30 PM EDT

No Quotes

Available for logged-in users onlyLogin HereorRegister

No Video

close
0.08448